Description of Physical Activity Effect on Neuromuscular Fatigue of Older People (ACTIFS-AGE)

There is a decrease in cardiovascular and neuromuscular functions, which leads to reduced performance with advancing age. Physical activity provides health benefits, prevents and treats cardiovascular and neuromuscular disease. The aim of this project is to describe cardiovascular and neuromuscular function in active and sedentary subjects of different ages.

Study Overview

Detailed Description

With advancing age, there is a decrease in cardiovascular and neuromuscular functions, which leads to reduced performance and increases the likelihood that older people will lose their independence. Physical activity provides health benefits, prevents and treats cardiovascular and neuromuscular disease. Indeed, recent data support the idea that it is fitness level, not age that explains physiological responses to exercise. However, although there are data about how quickly cardiovascular and neuromuscular functions decline throughout life, less is known on the extent physical activity can help mitigate the loss of these functions. The aim of this project is therefore to describe cardiovascular and neuromuscular function in active and sedentary subjects of different ages.

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Saint-Étienne, France, 42055
        • Recruiting
        • Chu de Saint-Etienne
        • Sub-Investigator:
          • David HUPIN, MD
        • Sub-Investigator:
          • Clément FOSCHIA, MD
        • Sub-Investigator:
          • Philippe BOIRON, MD
        • Principal Investigator:
          • Léonard FEASSON, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 18 to 35 for the young group, between 65 and 80 for the old group and over 80 for the very old group.
  • Signed consent for the study obtained
  • Subject affiliated or entitled to a social security scheme

Exclusion Criteria:

  • Pathology or surgical intervention causing a locomotor disorder
  • Neurological, cardiovascular or psychological pathology
  • Participants will be excluded if resting or exercise ECG responses show any abnormality, or if resting Heart Rate (HR) > 100 bmp, resting blood pressure > 144 (systolic) / 95 (diastolic) mmHg, pulmonary and or cardiac disease that could affect the health of the participant (arrhythmias and stroke)
  • Mini-Mental State Examination score < 20 (>80 years old)
  • Significant change in the amount of physical practice over the last 5 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Young, Active group

From 18 to 35 years old.

The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:

  • at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR
  • at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR
  • At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 Metabolic Equivalent of Task (MET)-minutes per week
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.
Active Comparator: Young, sedentary group
From 18 to 35 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.
Active Comparator: Old, Active group

From 65 to 80 years old.

The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:

  • at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR
  • at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR
  • At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 MET-minutes per week
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.
Active Comparator: Old sedentary group
From 65 to 80 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.
Active Comparator: Very old, Active group

From 81 years old.

The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:

  • at least 20 minutes of vigorous physical activity per day for 3 or more days per week OR
  • at least 30 minutes of moderate physical activity or walking per day for 5 or more days per week OR
  • At least 5 days of walking and moderate or vigorous physical activity, reaching a minimum of 600 MET-minutes per week
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.
Active Comparator: Very old sedentary group
From 81 years old. Subjects who are below these thresholds will be considered as sedentary. To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia. Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost. Maximum test on an endocycle (classic) to determine VO2max.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal voluntary contraction (MVC) of the knee extensor muscle measurement
Time Frame: At 48 hours
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
At 48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Voluntary activation measurement (%)
Time Frame: At 48 hours
The level of voluntary activation will be determined by the force increment obtained following stimulation performed during a condition of the muscle in a state of maximum contraction.
At 48 hours
Maximal voluntary contraction (MVC) of the plantar flexor muscle measurement
Time Frame: At 48 hours
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
At 48 hours
Maximal voluntary contraction (MVC) of the hand grip measurement
Time Frame: At 48 hours
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
At 48 hours
Cardiac variability(ms)
Time Frame: At 48 hours
24-hour measurement with an ECG holter for 24 hours.
At 48 hours
Muscle oxygenation (%)
Time Frame: At 48 hours
This is measured by a NIRS20 (near infrared spectroscopy, Oxysoft, Artinis, TheNetherlands)
At 48 hours
Balance test (s)
Time Frame: At 48 hours
This test, performed in unipedal support, consists of asking the subject to hold the unipedal position for as long as possible, on the lower limb of his choice.
At 48 hours
Test of Get-up-and-Go (s)
Time Frame: At 48 hours

For test of Get-up-and-Go, participants will be asked to stand from a seated position, walk 3 meters at their usual pace, turn around, walk back to the chair, and sit down.

Measured in seconds when performing test.

At 48 hours
Reaction force on the ground for each step (N)
Time Frame: At 72 hours
First, a maximum pace walking speed and a comfort speed will be measured in a corridor using photoelectric cells. Then, a biomechanical analysis of walking at several speeds (comfort walking, 2.5, 4 and 5.5 km/h) will be performed on an instrumented treadmill (Treadmetrix, Park City, Utah, United States). This treadmill allows the analysis of the reaction forces on the ground during the strides while controlling the speed of the walk. Each step will last approximately 30 seconds.
At 72 hours
Maximal oxygen consumption (VO2max) during an effort test on a cycloergometer
Time Frame: At 72 hours
At 72 hours
Functional Assessment of Chronic Illness Therapy (FACIT) questionnaire
Time Frame: At inclusion
Score from 0 to 52
At inclusion
Quality of life via the SF-36 questionnaire
Time Frame: At inclusion
This questionnaire is composed of 12 questions representing the eight most relevant domains to describe and evaluate quality of life. Score ranges from 0 to 100, with a higher score defining a more favorable health state.
At inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: LEONARD FEASSON, PHD, Centre Hospitalier Universitaire de Saint Etienne
  • Study Chair: Guillaume MILLET, PhD, UNIVERSITE DE SAINT ETIENNE

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2021

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 8, 2025

Study Registration Dates

First Submitted

February 10, 2022

First Submitted That Met QC Criteria

June 7, 2022

First Posted (Actual)

June 10, 2022

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 21CH033
  • ANSM (Other Identifier: 2025-A02220-49)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Questionnaires completion

Subscribe